AUS
NZ
UK
CA
USA
IND
Healthcare
.jpg)
AstraZeneca (AZN) shares: A long term buy from pharma space
November 24, 2021 11:49 AM GMT| By Suhita PoddarHighlights AstraZeneca opened new research and development called Discovery Centre (DISC) is worth about £1 billion, in Cambridge It is the biggest science lab in the UK, tied with Francis Crick Institute located in London Pharmaceut.....
2 pharma penny stocks returning 200% in a year: Buy call?
November 17, 2021 10:44 AM GMT| By Nidhi GuptaPharmaceutical firms often serve as attractive investment options for investors. These stocks belong to healthcare firms focused on research and development, production as well as distribution of pharmaceutical products. The booming healthcare indu.....
.jpg)
AstraZeneca (AZN) or Nuformix (NFX): Which pharma stock to buy?
November 12, 2021 11:53 AM GMT| By Suhita PoddarThe UK pharma and biotechnology sector has laid out certain recommendations to increase the attractiveness of the sector, according to a new report by industry body the Association of the British Pharmaceutical Industry (ABPI). Drug manufacturers .....
.jpg)
Should you buy these 2 pharma penny stocks now?
November 08, 2021 01:36 PM GMT| By Suhita PoddarThe biotech and life sciences sector in the UK has seen a record level of investment in the first 3 quarters of 2021, raising up to £3 billion, according to industry body BioIndsutry Association and data firm Clarivate. The first 3 quarters .....
Sunak increases healthcare spending by £44 bn: 2 stocks to buy
October 27, 2021 03:01 PM BST| By Suhita PoddarThe UK’s chancellor of exchequer, Rishi Sunak, boosted the UK’s resource expenditure on the healthcare sector in the Autumn Budget announced today. As per the latest spending review, the resource spending in the healthcare sector will .....
5 stocks that may benefit from Sunak’s new £1.4-bn investment fund
October 25, 2021 11:16 AM BST| By Priya BhandariHighlights The UK government is planning to launch a £1.4bn fund to attract more overseas investments. Over £800 million of the new investment fund will go to support production and supply chain of EVs. The UK government in a .....
100-300% return in a year! Should you buy these 2 AIM stocks?
October 22, 2021 11:43 AM BST| By Nidhi GuptaHighlights ValiRx inked a contract with a renowned London university to test new technology for the treatment of breast cancer. As per the terms of the contract, it will conduct preclinical tests on the drug candidate for nine months to validate.....
.jpg)
GSK & AZN: 2 dividend-paying pharma stocks for income investors
October 18, 2021 02:03 PM BST| By Nidhi GuptaThe UK pharmaceutical industry is a major global hub for the research, development and production of pharmaceuticals and also plays a crucial role in the country’s economy. Pharmaceutical companies gained heavily from the development and comm.....
GlaxoSmithKline (GSK): Should you hold it after split of headquarter?
October 11, 2021 03:23 PM BST| By Suhita PoddarHighlights GlaxoSmithKline announced plans for setting up two headquarters today, wherein its consumer healthcare business would have a new headquarter, and its existing pharma business will be relocated to another office. The HQ split is an im.....
Are these 2 pharma stocks good buy for long term growth?
October 08, 2021 11:49 AM BST| By Nidhi GuptaInvesting in pharmaceutical stocks is a growing trend, especially in times of political or economic uncertainty. For instance, during the Covid-19 crisis, pharmaceutical firms were in high demand as they offered medicines, products, and equipment n.....
.jpg)
Pfizer, J&J, AstraZeneca: What's the latest on Covid vaccines
October 06, 2021 07:14 AM BST| By Nidhi GuptaHighlights The US Food and Drug Administration approved the administration of a booster dose of the Pfizer/BioNTech vaccine in adults aged 65 years and above and others with a weak immune system. Johnson & Johnson requested for US FDA.....
.jpg)
Abingdon (ABDX) soars 39%. Is this covid-19 testing stock still a buy?
October 05, 2021 07:17 AM BST| By Suhita PoddarHighlights UK-based rapid test developer and maker Abingdon Health shares surged over 38 per cent on Monday, making it the highest riser on the LSE. The shares rose on reports that the company will soon start the manufacturing of a Covid saliva.....
.jpg)
Oxford Nanopore (ONT): What to expect after stellar listing?
October 01, 2021 10:29 AM BST| By Suhita PoddarUK based DNA sequencing biotechnology firm Oxford Nanopore Technologies PLC’s (LON: ONT) shares surged on listing on the LSE on Thursday, making it one of the best IPO debuts on the exchange. The company’s shares rose by over 45 per ce.....
.jpg)
Should you buy these pharma stocks with over 80% return in a year?
September 30, 2021 03:09 PM BST| By Nidhi GuptaHighlights For the half-year ended 30 June 2021, Oxford Biomedica’s revenue increased by 139% year-on-year to £81.3 million compared to £34.0 million in H1 2020. Indivior Plc’s operating profit for Q2 2021 increase.....
.jpg)
MyHealthChecked (M3HC) & Alliance (APH): Are these pharma stocks a buy now?
September 30, 2021 07:55 AM BST| By Nidhi GuptaHighlights MyHealthChecked had recently acquired Nell Health Ltd, a technology-led genetic-testing platform and provider of personalised nutrition solutions, for £1.2 million. Alliance Pharma declared an interim dividend of 0.563 pe.....
AstraZeneca (LON: AZN) to acquire Caelum Biosciences: Buy alert?
September 29, 2021 04:24 PM BST| By Suhita PoddarHighlights Anglo-Swedish pharma company, AstraZeneca’s Alexion is set to acquire the remaining stake in rare disease biotech firm Caelum Biosciences. The deal is worth up to US$ 150 million, with a potential facility for making additional.....
Sareum (SAR) returns 700% in a year: Is this small-cap share still a good buy?
September 13, 2021 03:35 PM BST| By Nidhi GuptaHIGHLIGHTS Saerum raised £2.37 million in June 2021 through two subscription contracts with high-net-worth individuals. In July 2021, the company received approval from the US Patent and Trademark Office for the use of SDC-1802 drug molec.....
.jpg)
Synairgen & Omega Diagnostics: 2 AIM pharma stocks for a healthy portfolio
September 09, 2021 08:34 AM BST| By Nidhi GuptaHighlights Omega Diagnostics filed for CE-mark on Covid-19 antigen self-test ‘Visitect’. Synairgen, last year generated £87.1 million to fund the SG018 Phase III trial. The exceptional pace of technological advancem.....
.jpg)
Open Orphan (ORPH) & Angle (AGL): 2 AIM pharma stocks to buy in September
September 06, 2021 01:21 PM BST| By Nidhi GuptaPharma stocks listed on AIM present attractive investment opportunities for investors seeking to diversify their portfolios, and they simultaneously offer ample growth prospects. AIM pharma stocks comprise smaller pharmaceutical companies that desi.....
UK may offer Covid-19 jabs to 12- 15-year-olds. Stocks to look at
September 01, 2021 09:24 AM BST| By Suhita PoddarHighlights NHS England to prepare for a potential extension of the Covid vaccination programme to all 12 to 15-year-olds from early September. No advice regarding vaccine rollout provided by JCVI yet, but forward planning to be started. .....
